Post-Doctoral Research Fellow: Hematologic Malignancy

Job ID
15328
Type
Regular Full-Time
Company
Fred Hutchinson Cancer Research Center
Location
US-WA-Seattle
Category
Laboratory Research Sciences

Overview

Cures Start Here. Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutch’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Careers Start Here.

 

A postdoctoral position is immediately available in the laboratory of Dr. Stanley Lee at Fred Hutchinson Cancer Research Center. The Lee lab has a longstanding interest in understanding how defects in RNA processing and chromatin regulation drive hematologic malignancies, and how to devise mechanism-based strategies to therapeutically target these pathways in cancer (PMIDs: 30107174, 27135740, 27603132, 31334570.) Fred Hutch also offers a great research environment including state-of-the-art Shared Resources and Core Facilities and a robust Postdoctoral Fellowship Program to provide advanced training for future scientific leaders.

Responsibilities

The successful candidate will be responsible for project design, execution, management and data analysis relating to RNA processing/chromatin regulation in stem cell biology and blood cancers. Projects will use a variety of experimental and computational approaches including in vitro and in vivo models (genetically engineered murine models (GEMMs) and patient derived xenografts (PDXs)), transcriptomic, epigenomic and proteomic analyses, molecular assays and functional genomics approaches. The fellow will work directly with the PI, members of the laboratory and external collaborators. The fellow will be expected to acquire a thorough understanding of the scientific literature, present in internal and external meetings, and draft manuscripts for peer-reviewed publications.

Qualifications

  • A recent PhD or MD/PhD in a relevant field
  • Strong background in RNA biology, chromatin biology, cancer genetics, and/or computational biology is highly desirable
  • Some experience in stem cell biology, immunology, and/or developmental biology
  • Experience in flow cytometry, cell culture and murine models
  • Research publications from graduate work
  • Excellent verbal and written communication skills
  • Ability to think and work independently and collaboratively in a team environment

Please apply online and include a CV, cover letter with a brief description of past research experience and future goals, and contact information for three references.

Our Commitment to Diversity

We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at hrops@fredhutch.org or by calling 206-667-4700.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed